Novel Stop-gain SORL1 Mutation in a Peruvian Family with Alzheimer’s Disease of the PeADI Study (P6-9.017)

Mario Cornejo‐Olivas; Anthony J. Griswold; Ana Saldarriaga‐Mayo; Pedro Mena; Richard Rodríguez; Larry Adams; Patrice L. Whitehead; Rosario Isasi; Maryenela Illanes‐Manrique; Elison Sarapura‐Castro; Farid Rajabli; Katalina McInerney; Karina Milla‐Neyra; Carla Manrique Enciso; Gary W. Beecham; Sheila Castro‐Suárez; Peter St George‐Hyslop; Ismael Araujo-Aliaga; Michael L. Cuccaro; Jeffery M. Vance; Margaret A. Pericak‐Vance

doi:10.1212/wnl.0000000000206562

Abstract

SORL1 risk variants have been reported in both early-onset and late-onset AD. The aim of this abstract is to report a SORL1 AD-risk variant within a Peruvian AD family.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Cornejo‐Olivas et al. (2024) studied this question.

synapsesocial.com/papers/68e6fcc5b6db643587677191 https://doi.org/10.1212/wnl.0000000000206562

View Full Paper

Ask AI

Bookmark

Share

Novel Stop-gain SORL1 Mutation in a Peruvian Family with Alzheimer’s Disease of the PeADI Study (P6-9.017)

Abstract

Discussion

Cite This Study

Novel Stop-gain SORL1 Mutation in a Peruvian Family with Alzheimer’s Disease of the PeADI Study (P6-9.017)

Abstract

Discussion

Cite This Study

Keep reading

Keep reading